Detalhe da pesquisa
1.
Phenotypes of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma.
Clin Gastroenterol Hepatol
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38604295
2.
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma.
Gastroenterology
; 164(1): 72-88.e18, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108710
3.
aProceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH).
Gastroenterol Hepatol
; : 502207, 2024 May 07.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38723772
4.
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.
Lancet Oncol
; 24(12): 1411-1422, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951222
5.
Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis.
J Hepatol
; 75(4): 865-878, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33992698
6.
Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals.
J Hepatol
; 72(3): 472-480, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31629779
7.
Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort.
J Hepatol
; 72(4): 702-710, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31726116
8.
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma.
J Hepatol
; 73(2): 315-327, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32173382
9.
Immune-related hepatitis related to checkpoint inhibitors: Clinical and prognostic factors.
Liver Int
; 40(8): 1906-1916, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32329119
10.
International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis.
Liver Int
; 40(6): 1467-1476, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32170821
11.
Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules.
J Hepatol
; 70(5): 874-884, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30684506
12.
Complete response under sorafenib in patients with hepatocellular carcinoma: Relationship with dermatologic adverse events.
Hepatology
; 67(2): 612-622, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28898447
13.
Corrigendum to "Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules" [J Hepatol (2019) 874-884].
J Hepatol
; 74(2): 491, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33317846
14.
Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma.
J Hepatol
; 65(2): 289-95, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27085251
15.
Corrigendum to 'Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis' [J Hepatol 75 (2021) 865-878].
J Hepatol
; 75(6): 1515, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34627652
16.
Unique genomic profile of fibrolamellar hepatocellular carcinoma.
Gastroenterology
; 148(4): 806-18.e10, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25557953
17.
Phylogenetic demonstration of hepatitis E infection transmitted by pork meat ingestion.
J Clin Gastroenterol
; 49(2): 165-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24637729
18.
Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis.
Gastroenterology
; 144(5): 1024-30, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23333348
19.
Hepatitis-C-Related Hepatocellular Carcinoma, Still a Relevant Etiology beyond a Hepatitis C Infection Cure.
Cancers (Basel)
; 16(8)2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38672603
20.
Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis.
Ann Surg Oncol
; 20(4): 1194-202, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22965574